EU new drug approvals down sharply in 2010
This article was originally published in Scrip
In 2010 the European Commission approved 22 new human-use chemical and biological drugs, including vaccines, significantly down on the 39 products authorised in 2009.
You may also be interested in...
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.